FluoroPharma Medical, Inc.
FluoroPharma Medical, Inc. (FPMI) Revenue
Annual & quarterly revenue history · segment & region breakdown
FPMI · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsFluoroPharma Medical, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2016.
Revenue trend
2016 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2016-12-31 | $0.00B | +$0.00B | — |
| 2015-12-31 | $0.00B | +$0.00B | — |
| 2014-12-31 | $0.00B | +$0.00B | — |
| 2013-12-31 | $0.00B | -$0.00B | -100.00% |
| 2008-12-31 | $0.00B | +$0.00B | +49.57% |
| 2007-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income FluoroPharma Medical, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
FluoroPharma Medical, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from FluoroPharma Medical, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
FPMI revenue · 4 questionsFPMI's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2016.
▸ Source: FMP · FluoroPharma Medical, Inc. SEC filings · GAAP · FluoroPharma Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026